Cargando…

Prothrombin complex concentrates for DOAC‐associated bleeding, global coagulation assays, and assessments of clinical hemostasis: How to gauge the impact?

Detalles Bibliográficos
Autores principales:	Shaw, Joseph R., Siegal, Deborah M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354417/ https://www.ncbi.nlm.nih.gov/pubmed/32685875 http://dx.doi.org/10.1002/rth2.12367

Ejemplares similares

The impact of prothrombin complex concentrates when treating DOAC-associated bleeding: a review
por: Hoffman, Maureane, et al.
Publicado: (2018)

Acquired deficiency of prothrombin complex coagulation factors in major bleeding is a therapeutic indication of 4‐factor prothrombin complex concentrates
por: Wiedermann, Christian J.
Publicado: (2020)

Role of prothrombin complex concentrate in perioperative coagulation therapy
por: Tanaka, Kenichi A, et al.
Publicado: (2014)

Retrospective review of Andexanet Alfa versus 4-Factor Prothrombin Complex Concentrate for reversal of DOAC-Associated Intracranial Hemorrhage
por: Troyer, Camille, et al.
Publicado: (2022)

Theoretical Modeling of Coagulation Management With Therapeutic Plasma or Prothrombin Complex Concentrate
por: Schöchl, Herbert, et al.
Publicado: (2017)

Influence of prothrombin complex concentrates on plasma coagulation in critically ill patients
por: Staudinger, T., et al.
Publicado: (1999)

Predictive Factors for Endoscopic Hemostasis in Patients with Upper Gastrointestinal Bleeding
por: Chung, Il Kwun
Publicado: (2014)

The Two-Stage “Prothrombin” Assay in Study of Bleeding and Clotting Disorders
por: Ferguson, John H., et al.
Publicado: (1955)

Prothrombin complex concentrate in the management of major bleeding induced by oral anticoagulant therapy
por: AlSheef, Mohammed, et al.
Publicado: (2022)

Spontaneous rectal sheath bleed while on DOAC anticoagulation
por: de Courcy, Louis, et al.
Publicado: (2023)

Prothrombin Complex Concentrates to Treat Coagulation Disturbances: An Overview With a Focus on Use in Infants and Children
por: Munlemvo, Dolly M., et al.
Publicado: (2022)

Thrombin generation, bleeding and hemostasis in humans: Protocol for a scoping review of the literature
por: Shaw, Joseph R., et al.
Publicado: (2023)

DOAC Dipstick Testing Can Reliably Exclude the Presence of Clinically Relevant DOAC Concentrations in Circulation
por: Margetić, Sandra, et al.
Publicado: (2022)

Three- versus four-factor prothrombin complex concentrate for the reversal of warfarin-induced bleeding
por: Holt, Tara, et al.
Publicado: (2018)

Effectiveness of prothrombin complex concentrate for the treatment of bleeding: A systematic review and meta‐analysis
por: van den Brink, Daan P., et al.
Publicado: (2020)

DOACs for VTE in patients with brain cancer and brain metastases: choices, choices, choices
por: Buka, Richard J., et al.
Publicado: (2022)

Treatment of the coagulation deficit during extracorporeal circulation in a porcine model by a prothrombin complex concentrate
por: Kaspereit, F, et al.
Publicado: (2010)

Prothrombin complex concentrate mitigates diffuse bleeding after cardiopulmonary bypass in a porcine model
por: Kaspereit, F., et al.
Publicado: (2010)

Management of the Bleeding Patient Receiving New Oral Anticoagulants: A Role for Prothrombin Complex Concentrates
por: Baumann Kreuziger, Lisa M., et al.
Publicado: (2014)

Safety and efficacy of prothrombin complex concentrate as first-line treatment in bleeding after cardiac surgery
por: Cappabianca, Giangiuseppe, et al.
Publicado: (2016)

Efficacy and safety of activated prothrombin complex concentrate for the reversal of vitamin K antagonist major bleeding
por: Sheikh-Taha, Marwan, et al.
Publicado: (2022)

Thromboembolism after treatment with 4-factor prothrombin complex concentrate or plasma for warfarin-related bleeding
por: Go, Alan S., et al.
Publicado: (2022)

PROTHROMBIN COMPLEX CONCENTRATE  IN EMERGENCY DEPARTMENT
por: Nesek Adam, Višnja, et al.
Publicado: (2022)

Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM(®))-guided administration of fibrinogen concentrate and prothrombin complex concentrate
por: Schöchl, Herbert, et al.
Publicado: (2010)

Prothrombin complex concentrate (Beriplex P/N) in severe bleeding: experience in a large tertiary hospital
por: Bruce, David, et al.
Publicado: (2008)

Prothrombin Complex Concentrate for Warfarin-Associated Intracranial Bleeding in Neurosurgical Patients: A Single-Center Experience
por: Mačiukaitienė, Jomantė, et al.
Publicado: (2018)

Clinical outcome of patients with a vitamin K antagonist‐associated bleeding treated with prothrombin complex concentrate
por: Brekelmans, Marjolein P. A., et al.
Publicado: (2017)

Four-factor prothrombin complex concentrate improves thrombin generation and prothrombin time in patients with bleeding complications related to rivaroxaban: a single-center pilot trial
por: Schenk, Bettina, et al.
Publicado: (2018)

Coagulation in chronic liver disease and the use of prothrombin complex concentrate for an emergent procedure: a case report and review of literature
por: Laubham, Matthew, et al.
Publicado: (2018)

Effects of Hyperglycemia and Diabetes Mellitus on Coagulation and Hemostasis
por: Li, Xiaoling, et al.
Publicado: (2021)

Prothrombin complex concentrates in warfarin anticoagulation reversal
por: Costa-Lima, Carolina, et al.
Publicado: (2012)

Prothrombin Complex Concentrates Only After Thromboelastography
por: Muggleton, Ellis, et al.
Publicado: (2019)

Prothrombin complex concentrate in surgical patients: retrospective evaluation of vitamin K antagonist reversal and treatment of severe bleeding
por: Schick, Kerstin S, et al.
Publicado: (2009)

Four‐factor prothrombin complex concentrate reverses apixaban‐associated bleeding in a rabbit model of acute hemorrhage
por: Herzog, E., et al.
Publicado: (2015)

Prothrombin, alone or in complex concentrates or plasma, reduces bleeding in a mouse model of blood exchange-induced coagulopathy
por: Eltringham-Smith, Louise J., et al.
Publicado: (2019)

Four-factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitors versus Warfarin in Life-threatening Bleeding
por: Rech, Megan A., et al.
Publicado: (2021)

Global assays of hemostasis in the diagnostics of hypercoagulation and evaluation of thrombosis risk
por: Lipets, Elena N, et al.
Publicado: (2015)

Administration of fibrinogen concentrate combined with prothrombin complex maintains hemostasis in children undergoing congenital heart repair (a long‐term propensity score‐matched study)
por: Velik‐Salchner, Corinna, et al.
Publicado: (2021)

Four-factor prothrombin complex concentrate (Beriplex® P/N) is superior to three-factor prothrombin complex concentrate for reversal of coumarin anticoagulation
por: Herzog, E, et al.
Publicado: (2015)

Hemostasis, bleeding and thrombosis in liver disease
por: Flores, Brisas, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_tcaop24hp0c809fo9sc9889k8s